Skip to Content
Merck
  • Detection of anti-Pneumocystis jirovecii antibodies in human serum using a recombinant synthetic multi-epitope kexin-based antigen.

Detection of anti-Pneumocystis jirovecii antibodies in human serum using a recombinant synthetic multi-epitope kexin-based antigen.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2020-06-20)
Ana Luísa Tomás, Fernando Cardoso, Bruno de Sousa, Olga Matos
ABSTRACT

Interest in the detection of specific anti-Pneumocystis jirovecii antibodies has emerged as less-invasive alternative diagnostic approaches. Here is presented the performance of an ELISA based on a recombinant synthetic multi-epitope kexin 1 (Kex1) antigen of P. jirovecii, previously developed. Results showed that IgM anti-Kex1 levels were found significantly increased in patients with Pneumocystis pneumonia (PcP) compared with non-PcP cases (p < 0.001), allowing a diagnostic performance of PcP with a 70.8% sensitivity and a 75.0% specificity. These results suggest that this Kex1-based ELISA is a promising tool toward the serodiagnosis of PcP when the standard methods are difficult to perform.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Human IgG−Alkaline Phosphatase antibody, Mouse monoclonal, clone GG-5, purified from hybridoma cell culture
Sigma-Aldrich
Anti-Human IgM (μ-chain specific)-Alkaline Phosphatase, Mouse monoclonal, clone MB-11, purified from hybridoma cell culture